Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical features and treatment of maturity onset diabetes of the young (MODY)Diabetes, Metabolic Syndrome and Obesity, 2012
- Genetic and clinical characteristics of patients with HNF1A gene variations from the German–Austrian DPV databaseEuropean Journal of Endocrinology, 2011
- Maturity onset diabetes of the young and pregnancyBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitroDiabetic Medicine, 2010
- Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemiaHuman Mutation, 2009
- Identification of a Novel β-Cell Glucokinase (GCK) Promoter Mutation (−71G>C) That ModulatesGCKGene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in HumansDiabetes, 2009
- Mutations in GCK and HNF‐1α explain the majority of cases with clinical diagnosis of MODY in SpainClinical Endocrinology, 2007
- Genetic and clinical characteristics of maturity‐onset diabetes of the youngDiabetes, Obesity and Metabolism, 2004
- Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the youngHuman Mutation, 2003
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002